Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
20.99
-0.36 (-1.69%)
At close: May 15, 2026, 4:00 PM EDT
21.05
+0.06 (0.29%)
After-hours: May 15, 2026, 7:58 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $2.29 billion as of May 15, 2026. Its market cap has increased by 307.03% in one year.
Market Cap
2.29B
Enterprise Value
2.00B
1-Year Change
307.03%
Ranking
Category
Stock Price
$20.99
Market Cap Chart
Since May 17, 2021, Definium Therapeutics's market cap has increased from $1.34B to $2.29B, an increase of 70.49%. That is a compound annual growth rate of 11.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.28B | 98.57% |
| Dec 31, 2025 | 1.15B | 94.23% |
| Dec 31, 2024 | 592.07M | 301.61% |
| Dec 29, 2023 | 147.42M | 76.44% |
| Dec 30, 2022 | 83.55M | -85.66% |
| Dec 31, 2021 | 582.65M | -56.61% |
| May 17, 2021 | 1.34B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 2.52B |
| IDEAYA Biosciences | 2.48B |
| Celldex Therapeutics | 2.46B |
| Ultragenyx Pharmaceutical | 2.45B |
| Nektar Therapeutics | 2.38B |
| Immunome | 2.36B |
| Relay Therapeutics | 2.34B |
| Zai Lab | 2.31B |